Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan effects on cerebral blood flow and haemodynamics after recent stroke
2006-005082-19Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan in essential hypertension, ischemic stroke and brain hemorrhage (ICH), sponsored by University of Nottingham. Primary endpoints: Cerebral blood flow, Cerebral perfusion pressure and 1 more. Started Oct 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
essential hypertensionischemic strokebrain hemorrhage (ICH)
Beyond the preview
Go deeper on 2006-005082-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005082-19.